D & M Company Toekomstige groei
Future criteriumcontroles 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for D & M Company.
Belangrijke informatie
n/a
Groei van de winst
n/a
Groei van de winst per aandeel
| Healthcare winstgroei | 9.0% |
| Inkomstengroei | n/a |
| Toekomstig rendement op eigen vermogen | n/a |
| Dekking van analisten | Low |
| Laatst bijgewerkt | 11 Jun 2024 |
Recente toekomstige groei-updates
Geen updates
Recent updates
Winst- en omzetgroeiprognoses
| Datum | Inkomsten | Inkomsten | Vrije kasstroom | Geldmiddelen uit operationele activiteiten | Gem. Aantal analisten |
|---|---|---|---|---|---|
| 5/31/2025 | 1,390 | 200 | N/A | N/A | 1 |
| 5/31/2024 | 1,189 | 177 | -784 | -782 | N/A |
| 5/31/2023 | 1,111 | 171 | N/A | N/A | N/A |
| 5/31/2022 | 930 | 145 | N/A | N/A | N/A |
Toekomstige groeivoorspellingen analisten
Verdiensten versus spaarpercentage: Insufficient data to determine if 189A's forecast earnings growth is above the savings rate (0.3%).
Winst versus markt: Insufficient data to determine if 189A's earnings are forecast to grow faster than the JP market
Hoge groeiwinsten: Insufficient data to determine if 189A's earnings are expected to grow significantly over the next 3 years.
Omzet versus markt: Insufficient data to determine if 189A's revenue is forecast to grow faster than the JP market.
Hoge groei-inkomsten: Insufficient data to determine if 189A's revenue is forecast to grow faster than 20% per year.
Groeiprognoses winst per aandeel
Toekomstig rendement op eigen vermogen
Toekomstige ROE: Insufficient data to determine if 189A's Return on Equity is forecast to be high in 3 years time